Enterprise Tech Ecosystem Series: Novartis AG 2025
Description
Enterprise Tech Ecosystem Series: Novartis AG 2025
Summary
Novartis AG (Novartis) is a pharmaceutical company that is engaged in the research, development, manufacturing, distribution, marketing, and sale of innovative medicines. It offers a range of products in therapeutic areas such as cardiovascular, renal and metabolic, immunology, ophthalmology, respiratory, global health, neuroscience, and oncology. The company offers its products to pharmacists, private health systems, government agencies, physicians, hospitals, insurance groups, managed care providers, pharmacy benefit managers, and government-supported healthcare systems through brands such as Entresto, Cosentyx, Kesimpta, Kisqali, and Tasigna, among others, globally. It operates manufacturing facilities in the US, Switzerland, Austria, Slovenia, China, France, and Italy.
The report provides information and insights into Novartis's tech activities, including -
Summary
Novartis AG (Novartis) is a pharmaceutical company that is engaged in the research, development, manufacturing, distribution, marketing, and sale of innovative medicines. It offers a range of products in therapeutic areas such as cardiovascular, renal and metabolic, immunology, ophthalmology, respiratory, global health, neuroscience, and oncology. The company offers its products to pharmacists, private health systems, government agencies, physicians, hospitals, insurance groups, managed care providers, pharmacy benefit managers, and government-supported healthcare systems through brands such as Entresto, Cosentyx, Kesimpta, Kisqali, and Tasigna, among others, globally. It operates manufacturing facilities in the US, Switzerland, Austria, Slovenia, China, France, and Italy.
The report provides information and insights into Novartis's tech activities, including -
- Insights of its digital transformation strategies and innovation programs.
- Overview of technology initiatives covering partnerships, product launches, investments, and acquisitions.
- Insights on each technology initiative including technology theme, objective, and benefits.
- Details of estimated ICT budgets and major ICT contracts.
- The report provides insights into company’s tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.
- Gain insights into Novartis' tech operations.
- Gain insights into its tech strategies and innovation initiatives.
- Gain insights into its technology themes under focus.
- Gain insights into various product launches, partnerships, investments, and acquisitions.
Table of Contents
47 Pages
- Novartis’ Overview
- Novartis’ Digital Transformation Strategy
- Novartis’ Accelerators, Incubators, and Innovation Programs
- Novartis’ Technology Focus
- Novartis’ Technology Initiatives
- Novartis’ Venture Arm
- Novartis’ Investments
- Novartis’ Acquisitions
- Novartis’ Tech Ecosystem
- Novartis’ ICT Budget & Contracts
- Novartis’ Senior Management Team
- Our Thematic Scorecard for the Pharmaceuticals and Healthcare Sector
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
